The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis
Open Access
- 30 July 2019
- Vol. 11 (8), 1074
- https://doi.org/10.3390/cancers11081074
Abstract
Anaplastic lymphoma kinase (ALK) is a tyrosine kinase involved in neuronal and gut development. Initially discovered in T cell lymphoma, ALK is frequently affected in diverse cancers by oncogenic translocations. These translocations involve different fusion partners that facilitate multimerisation and autophosphorylation of ALK, resulting in a constitutively active tyrosine kinase with oncogenic potential. ALK fusion proteins are involved in diverse cellular signalling pathways, such as Ras/extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase (PI3K)/Akt and Janus protein tyrosine kinase (JAK)/STAT. Furthermore, ALK is implicated in epigenetic regulation, including DNA methylation and miRNA expression, and an interaction with nuclear proteins has been described. Through these mechanisms, ALK fusion proteins enable a transcriptional programme that drives the pathogenesis of a range of ALK-related malignancies.This publication has 166 references indexed in Scilit:
- DNA methylation-associated silencing of tumor-suppressor microRNAs in cancerOncogene, 2011
- Lack of TNFα expression protects anaplastic lymphoma kinase-positive T-cell lymphoma (ALK+ TCL) cells from apoptosisProceedings of the National Academy of Sciences of the United States of America, 2009
- miR-155 gene: A typical multifunctional microRNABiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- A mouse model for EML4-ALK -positive lung cancerProceedings of the National Academy of Sciences of the United States of America, 2008
- Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformationProceedings of the National Academy of Sciences of the United States of America, 2008
- NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responsesProceedings of the National Academy of Sciences of the United States of America, 2006
- Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyLeukemia, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- STATs in oncogenesisOncogene, 2000
- Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNACell, 1992